A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer
with Uncommon EGFR Mutations

A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer
with Uncommon EGFR Mutations

Lung cancer is the most common cancer and the leading cause of cancer death. Non-small cell lung cancer (NSCLC) represents over 85% of all lung cancers, and up to 50% of Asian NSCLC patients harboring epidermal growth factor receptor (EGFR) gene mutations. A number of studies have consistently demon...

Full description

Bibliographic Details
Main Authors: Wenxing DU, Yang WO, Tong LU, Yuanyong WANG, Wenjie JIAO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
Epidermal Growth Factor Receptor
Uncommon Mutation
Tyrosine Kinase Inhibitor
Lung neoplasms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.09.07

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.09.07

Similar Items